CC BY 4.0 · The Arab Journal of Interventional Radiology 2024; 08(02): 100-104
DOI: 10.1055/s-0044-1785526
Original Article

Trans-splenic Approach for Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation in Patients with Portal Vein Thrombosis

Maryam Boumezrag
1   Medstar Georgetown University Hospital, Washington, District of Columbia, United States
George Lynskey
2   National Vascular Physicians, National Harbor, Maryland, United States
Saher Sabri
1   Medstar Georgetown University Hospital, Washington, District of Columbia, United States
› Author Affiliations


Purpose The aim of this study was to evaluate the safety and efficacy of using a trans-splenic approach for transjugular intrahepatic portosystemic shunt (TIPS) creation in patients with portal vein thrombosis. (PVT).

Material and Methods A retrospective review was performed on 36 consecutive patients with PVT who underwent TIPS using a trans-splenic approach from February 2018 to June 2021. Preprocedural data including demographic information and Model for End-Stage Liver Disease (MELD) scores were obtained. Outcomes measured included technical success, clinical success, complications, and survival.

Results Technical success was achieved in 32 of 36 patients (89%). During the follow-up period, 16 of 32 (50%) required secondary TIPS interventions, most of which were planned as part of a staged procedure. 30/32 (94%) had stent patency on their most recent follow-up, with a median follow-up of 164 days. No patients had variceal bleeding following TIPS. 12 of 32 (38%) patients underwent successful transplant after TIPS. Anatomical portal vein end-to-end anastomosis was achieved in 11/12 (92%) patients.

Conclusion The trans-splenic approach to TIPS is a reliable alternative to traditional TIPS in patients with PVT and provides high technical and clinical success rates. This technique can also be utilized to improve future liver transplant outcomes by facilitating anatomic portal vein end-to-end anastomoses.

Publication History

Article published online:
19 April 2024

© 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (

Thieme Medical and Scientific Publishers Pvt. Ltd.
A-12, 2nd Floor, Sector 2, Noida-201301 UP, India

  • References

  • 1 Rajani R, Björnsson E, Bergquist A. et al. The epidemiology and clinical features of portal vein thrombosis: a multicentre study. Aliment Pharmacol Ther 2010; 32 (09) 1154-1162
  • 2 Wu M, Schuster M, Tadros M. Update on management of portal vein thrombosis and the role of novel anticoagulants. J Clin Transl Hepatol 2019; 7 (02) 154-164
  • 3 Gadani S, Partovi S, Levitin A. et al. Narrative review of portal vein thrombosis in cirrhosis: pathophysiology, diagnosis, and management from an interventional radiology perspective. Cardiovasc Diagn Ther 2022; 12 (01) 135-146
  • 4 Klinger C, Riecken B, Schmidt A. et al. Transjugular local thrombolysis with/without TIPS in patients with acute non-cirrhotic, non-malignant portal vein thrombosis. Dig Liver Dis 2017; 49 (12) 1345-1352
  • 5 Sharma AK, Kaufman DC. TIPS performed in a patient with complete portal vein thrombosis. Radiol Case Rep 2017; 12 (02) 327-330
  • 6 Tuite DJ, Rehman J, Davies MH, Patel JV, Nicholson AA, Kessel DO. Percutaneous transsplenic access in the management of bleeding varices from chronic portal vein thrombosis. J Vasc Interv Radiol 2007; 18 (12) 1571-1575
  • 7 Zhu K, Meng X, Zhou B. et al. Percutaneous transsplenic portal vein catheterization: technical procedures, safety, and clinical applications. J Vasc Interv Radiol 2013; 24 (04) 518-527
  • 8 Sacks D, McClenny TE, Cardella JF, Lewis CA. Society of Interventional Radiology clinical practice guidelines. J Vasc Interv Radiol 2003; 14 (9 Pt 2): S199-S202
  • 9 Haskal ZJ, Duszak Jr R, Furth EE. Transjugular intrahepatic transcaval portosystemic shunt: the gun-sight approach. J Vasc Interv Radiol 1996; 7 (01) 139-142
  • 10 Nery F, Chevret S, Condat B. et al; Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire. Causes and consequences of portal vein thrombosis in 1,243 patients with cirrhosis: results of a longitudinal study. Hepatology 2015; 61 (02) 660-667
  • 11 Shukla A, Giri S. Portal vein thrombosis in cirrhosis. J Clin Exp Hepatol 2022; 12 (03) 965-979
  • 12 Maruyama H, Okugawa H, Takahashi M, Yokosuka O. De novo portal vein thrombosis in virus-related cirrhosis: predictive factors and long-term outcomes. Am J Gastroenterol 2013; 108 (04) 568-574
  • 13 Senzolo M, Riva N, Dentali F, Sartori MT, Ageno W. IRSVT Study Investigators. Portal vein thrombosis in decompensated cirrhosis: rationale for treatment. Clin Transl Gastroenterol 2019; 10 (04) e00026
  • 14 D'Amico G, De Franchis R. Cooperative Study Group. Upper digestive bleeding in cirrhosis. Post-therapeutic outcome and prognostic indicators. Hepatology 2003; 38 (03) 599-612
  • 15 Hepatobiliary Disease Study Group, Chinese Society of Gastroenterology, Chinese Medical Association. Consensus for management of portal vein thrombosis in liver cirrhosis (2020, Shanghai). [published correction appears in J Dig Dis. 2021 May;22(5):295] J Dig Dis 2021; 22 (04) 176-186
  • 16 Thornburg B, Desai K, Hickey R. et al. Portal vein recanalization and transjugular intrahepatic portosystemic shunt creation for chronic portal vein thrombosis: technical considerations. Tech Vasc Interv Radiol 2016; 19 (01) 52-60
  • 17 Qi X, Han G. Transjugular intrahepatic portosystemic shunt in the treatment of portal vein thrombosis: a critical review of literature. Hepatol Int 2012; 6 (03) 576-590
  • 18 Paskonis M, Jurgaitis J, Mehrabi A. et al. Surgical strategies for liver transplantation in the case of portal vein thrombosis–current role of cavoportal hemitransposition and renoportal anastomosis. [published correction appears in Clin Transplant. 2006 Nov-Dec;20(6):799] Clin Transplant 2006; 20 (05) 551-562
  • 19 Robles R, Fernandez JA, Hernández Q. et al. Eversion thromboendovenectomy in organized portal vein thrombosis during liver transplantation. Clin Transplant 2004; 18 (01) 79-84
  • 20 Bonnet S, Sauvanet A, Bruno O. et al. Long-term survival after portal vein arterialization for portal vein thrombosis in orthotopic liver transplantation. Gastroenterol Clin Biol 2010; 34 (01) 23-28
  • 21 Habib A, Desai K, Hickey R. et al. Portal vein recanalization-transjugularintrahepatic portosystemic shunt using the transsplenic approach to achieve transplant candidacy in patients with chronic portal vein thrombosis. J Vasc Interv Radiol 2015; 26 (04) 499-506
  • 22 Bilbao JI, Vivas I, Elduayen B. et al. Limitations of percutaneous techniques in the treatment of portal vein thrombosis. Cardiovasc Intervent Radiol 1999; 22 (05) 417-422
  • 23 Bilbao JI, Elorz M, Vivas I, Martínez-Cuesta A, Bastarrika G, Benito A. Transjugular intrahepatic portosystemic shunt (TIPS) in the treatment of venous symptomatic chronic portal thrombosis in non-cirrhotic patients. Cardiovasc Intervent Radiol 2004; 27 (05) 474-480
  • 24 Probst P, Rysavy JA, Amplatz K. Improved safety of splenoportography by plugging of the needle tract. AJR Am J Roentgenol 1978; 131 (03) 445-449
  • 25 Chu HH, Kim HC, Jae HJ. et al. Percutaneous transsplenic access to the portal vein for management of vascular complication in patients with chronic liver disease. Cardiovasc Intervent Radiol 2012; 35 (06) 1388-1395